Trial Profile
A Phase I trial of RP-2000
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs BX 2000 (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- 23 Nov 2018 New trial record
- 07 Nov 2018 According to a Recro Pharma media release, the company expects to initiate this trial in 2019.